Clofarabine (Amneal Biosciences LLC)


Welcome to the PulseAid listing for the Clofarabine drug offered from Amneal Biosciences LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amneal Biosciences LLC
NON-PROPRIETARY NAME: Clofarabine
SUBSTANCE NAME: CLOFARABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-11-06
END MARKETING DATE: 0000-00-00


Clofarabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionClofarabine from Amneal Biosciences LLC
LABELER NAME: Amneal Biosciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2017-11-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70121-1236_03fa52bc-9691-4d08-9fc3-252bb19f8607
PRODUCT NDC: 70121-1236
APPLICATION NUMBER: ANDA208857

Other CLOFARABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Biosciences LLCClofarabine
Fresenius-KabiCLOFARABINE
Mylan Institutional LLCclofarabine
sanofi-aventis U.S. LLCClolar